Literature DB >> 28152243

Self-gated fetal cardiac MRI with tiny golden angle iGRASP: A feasibility study.

Kostas Haris1,2, Erik Hedström2,3, Sebastian Bidhult2, Frederik Testud4, Nicos Maglaveras1, Einar Heiberg2, Stefan R Hansson5, Håkan Arheden2, Anthony H Aletras1,2.   

Abstract

PURPOSE: To develop and assess a technique for self-gated fetal cardiac cine magnetic resonance imaging (MRI) using tiny golden angle radial sampling combined with iGRASP (iterative Golden-angle RAdial Sparse Parallel) for accelerated acquisition based on parallel imaging and compressed sensing.
MATERIALS AND METHODS: Fetal cardiac data were acquired from five volunteers in gestational week 29-37 at 1.5T using tiny golden angles for eddy currents reduction. The acquired multicoil radial projections were input to a principal component analysis-based compression stage. The cardiac self-gating (CSG) signal for cardiac gating was extracted from the acquired radial projections and the iGRASP reconstruction procedure was applied. In all acquisitions, a total of 4000 radial spokes were acquired within a breath-hold of less than 15 seconds using a balanced steady-state free precession pulse sequence. The images were qualitatively compared by two independent observers (on a scale of 1-4) to a single midventricular cine image from metric optimized gating (MOG) and real-time acquisitions.
RESULTS: For iGRASP and MOG images, good overall image quality (2.8 ± 0.4 and 2.6 ± 1.3, respectively, for observer 1; 3.6 ± 0.5 and 3.4 ± 0.9, respectively, for observer 2) and cardiac diagnostic quality (3.8 ± 0.4 and 3.4 ± 0.9, respectively, for observer 1; 3.6 ± 0.5 and 3.6 ± 0.9, respectively, for observer 2) were obtained, with visualized myocardial thickening over the cardiac cycle and well-defined myocardial borders to ventricular lumen and liver/lung tissue. For iGRASP, MOG, and real time, left ventricular lumen diameter (14.1 ± 2.2 mm, 14.2 ± 1.9 mm, 14.7 ± 1.1 mm, respectively) and wall thickness (2.7 ± 0.3 mm, 2.6 ± 0.3 mm, 3.0 ± 0.4, respectively) showed agreement and no statistically significant difference was found (all P > 0.05). Images with iGRASP tended to have higher overall image quality scores compared with MOG and particularly real-time images, albeit not statistically significant in this feasibility study (P > 0.99 and P = 0.12, respectively).
CONCLUSION: Fetal cardiac cine MRI can be performed with iGRASP using tiny golden angles and CSG. Comparison with other fetal cardiac cine MRI methods showed that the proposed method produces high-quality fetal cardiac reconstructions. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 1 J. MAGN. RESON. IMAGING 2017;46:207-217.
© 2017 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  cardiac MRI; compressed sensing; fetal MRI; golden-angle radial sampling; image reconstruction; self-gated

Mesh:

Year:  2017        PMID: 28152243     DOI: 10.1002/jmri.25599

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  12 in total

1.  Fetal dynamic phase-contrast MR angiography using ultrasound gating and comparison with Doppler ultrasound measurements.

Authors:  B P Schoennagel; J Yamamura; F Kording; R Fischer; P Bannas; G Adam; H Kooijman; C Ruprecht; K Fehrs; M Tavares de Sousa
Journal:  Eur Radiol       Date:  2019-01-07       Impact factor: 5.315

2.  GRASP-Pro: imProving GRASP DCE-MRI through self-calibrating subspace-modeling and contrast phase automation.

Authors:  Li Feng; Qiuting Wen; Chenchan Huang; Angela Tong; Fang Liu; Hersh Chandarana
Journal:  Magn Reson Med       Date:  2019-08-10       Impact factor: 4.668

3.  Dynamic fetal cardiovascular magnetic resonance imaging using Doppler ultrasound gating.

Authors:  Fabian Kording; Jin Yamamura; Manuela Tavares de Sousa; Christian Ruprecht; Erik Hedström; Anthony H Aletras; P Ellen Grant; Andrew J Powell; Kai Fehrs; Gerhard Adam; Hendrik Kooijman; Bjoern P Schoennagel
Journal:  J Cardiovasc Magn Reson       Date:  2018-03-12       Impact factor: 5.364

4.  Evaluation of a Portable Doppler Ultrasound Gating Device for Fetal Cardiac MR Imaging: Initial Results at 1.5T and 3T.

Authors:  Fabian Kording; Bjoern P Schoennagel; Manuela Tavares de Sousa; Kai Fehrs; Gerhard Adam; Jin Yamamura; Christian Ruprecht
Journal:  Magn Reson Med Sci       Date:  2018-02-21       Impact factor: 2.471

5.  Fetal XCMR: a numerical phantom for fetal cardiovascular magnetic resonance imaging.

Authors:  Christopher W Roy; Davide Marini; William Paul Segars; Mike Seed; Christopher K Macgowan
Journal:  J Cardiovasc Magn Reson       Date:  2019-05-23       Impact factor: 5.364

Review 6.  Fetal Cardiac MRI: A Review of Technical Advancements.

Authors:  Christopher W Roy; Joshua F P van Amerom; Davide Marini; Mike Seed; Christopher K Macgowan
Journal:  Top Magn Reson Imaging       Date:  2019-10

7.  Fetal iGRASP cine CMR assisting in prenatal diagnosis of complicated cardiac malformation with impact on delivery planning.

Authors:  Misha Bhat; Kostas Haris; Sebastian Bidhult; Petru Liuba; Anthony H Aletras; Erik Hedström
Journal:  Clin Physiol Funct Imaging       Date:  2019-03-08       Impact factor: 2.273

8.  Free-breathing fetal cardiac MRI with doppler ultrasound gating, compressed sensing, and motion compensation.

Authors:  Kostas Haris; Erik Hedström; Fabian Kording; Sebastian Bidhult; Katarina Steding-Ehrenborg; Christian Ruprecht; Einar Heiberg; Håkan Arheden; Anthony H Aletras
Journal:  J Magn Reson Imaging       Date:  2019-06-22       Impact factor: 4.813

9.  Utility of Fetal Cardiovascular Magnetic Resonance for Prenatal Diagnosis of Complex Congenital Heart Defects.

Authors:  Daniel Ryd; Katrin Fricke; Misha Bhat; Håkan Arheden; Petru Liuba; Erik Hedström
Journal:  JAMA Netw Open       Date:  2021-03-01

10.  Multidimensional fetal flow imaging with cardiovascular magnetic resonance: a feasibility study.

Authors:  Datta Singh Goolaub; Christopher W Roy; Eric Schrauben; Dafna Sussman; Davide Marini; Mike Seed; Christopher K Macgowan
Journal:  J Cardiovasc Magn Reson       Date:  2018-11-29       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.